Live Breaking News & Updates on Takeda Refer Company|Page 11

Stay updated with breaking news from Takeda refer company. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Takeda: CHMP Recommends Approval Of Dengue Vaccine Candidate, TAK-003

TOKYO (dpa-AFX) - Takeda (TAK) announced the CHMP of the European Medicines Agency recommended the approval of the company's dengue vaccine candidate, TAK-003, for the prevention of dengue disease ....

Gary Dubin , European Medicines Agency , More Such Health News , Global Vaccine Business Unit ,

Takeda Pharmaceutical Company Limited: Takeda Receives Positive CHMP Opinion Recommending Approval of Dengue Vaccine Candidate in EU and Dengue-Endemic Countries

TAK-003 Recommended for the Prevention of Dengue Disease Caused by Any Dengue Virus Serotype in Individuals Four Years of Age and Older in the EU and in Dengue-Endemic Countries Participating in ....

Sri Lanka , United States , Dominican Republic , Jawa Tengah , Gary Dubin , Eng Eong , South East Asia , Rachel Higgins , Jun Saito , Centers For Disease , World Health Organization , International Media , Data Monitoring Committee , Indonesia National Agency For Drug , Exchange Commission , Takeda Pharmaceutical Company Limited , European Medicines Agency , European Centre For Disease Prevention , Natural Resources Defense Council , Committee For Medicinal Products Human Use , Dengue Disease Caused , Any Dengue Virus Serotype , Individuals Four Years , Dengue Endemic Countries Participating , Efficacy Data , Pivotal Phase ,

Japanese company to buy Oklahoma wind energy | The Journal Record

Takeda will purchase approximately 350,000 megawatt-hours of electricity annually from Enel. ....

United States , Hannah Badrei , Paolo Romanacci , Enel Group , Edison Energy , Seven Cowboy Wind Project , Enel Green Power , Enel North America , Enel Green , Power Purchase Agreement ,

Takeda: Maribavir Gets Positive CHMP Opinion To Treat Post-transplant Cytomegalovirus Refractory

BRUSSELS (dpa-AFX) - Takeda Pharmaceutical Co. Ltd. (TAK) announced Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has recommended the approval ....

Bruxelles Capitale , European Union , Takeda Pharmaceutical Co , European Commission , More Such Health News , European Medicines Agency , Medicinal Products , Human Use , Without Resistance ,

Takeda Pharmaceutical Company Limited: Takeda Receives Positive CHMP Opinion for Maribavir for the Treatment of Adults with Post-transplant Cytomegalovirus (CMV) Refractory (With or Without Resistance) to Prior Therapies

If Approved, Maribavir Would be the First and Only Inhibitor of CMV-specific UL97 Protein Kinase in the EU for Treatment of Adults with Post-transplant CMV Refractory (With or Without Resistance) to ....

United States , Daniel Curran , Abhi Basu , Jun Saito , Erin Marie Beals , European Commission , Drug Administration , International Media , Exchange Commission , European Union , Takeda Pharmaceutical Company Limited , European Medicines Agency , Committee For Medicinal Products Human Use , Maribavir Would , Only Inhibitor , Without Resistance , Opinion Based , Conventional Therapies , Study Week , Most Common , Serious Post Transplant Infections , Can Lead , Transplanted Organ , Medicinal Products , Human Use , Rare Diseases Therapeutic Area ,